Across TCGA pan-cancer cohorts, OR52K1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of OR52K1’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where OR52K1 RNA is repressed in tumor relative to normal tissue. In most cancer types OR52K1 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.
LUSC and KIRC are the cancer types where OR52K1 tumor–normal differential expression is most reproducible.